Le Lézard
Classified in: Health, Sports and recreation
Subject: AWD

Team Novo Nordisk's David Lozano Captures First Professional Win


KIGALI, Rwanda, Aug. 11, 2018 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all-diabetes professional cycling team, earned a historic win Saturday when David Lozano (ESP) soloed to victory on Stage 7 at the Tour du Rwanda. This win marks the team's second victory in its six-year history.

"For Team Novo Nordisk, the Team Type 1 Foundation, every person in Rwanda with diabetes, and the 437 million people around the world affected by this condition, this win is a win for all of us," Team Novo Nordisk CEO and Co-Founder Phil Southerland said. "David wanted this win so badly, and he fought hard on a tough and brutal stage. He is a champion and together we are changing diabetes in Rwanda!"

Beginning in Musanze, the 107-kilometer stage featured two intermediate sprints and six categorized climbs with the final one serving as a summit finish. Attacks flew from the start and Team Novo Nordisk's Joonas Henttala (FIN) made the initial break. The group splintered on the first climb. When the raced reached Kigali, Lozano had bridged with a small group of riders to make a nine-man front group. Heading up the final climb, Lozano attacked, dropped the other escapees, and soloed to the win on the penultimate stage.

"This win is so important for our team, myself and all the people around the world affected by diabetes," Lozano said. "It is absolutely amazing to be here and take this win in Rwanda. This is such a special place and I'm honored to stand on the top step of the podium and proudly show our Changing Diabetes jersey."

Hailing from Terrassa, Spain, Lozano was an 11-time Spanish national mountain bike and cyclocross champion. At 22 and the peak of his career, he was diagnosed with type 1 diabetes, and his team immediately broke his contract. He connected with Southerland via social media soon after his diagnosis and was invited to race with the newly forming Team Novo Nordisk. He is currently in his sixth year with the project; career highlights include fifth overall at the Tour of Estonia (2018) and winning the king of the mountain's classification at Cholet Pays De Loire (2014). Today's win serves as his fifth top 5 finish at this week's Tour du Rwanda.

The world's first all-diabetes pro cycling team concludes racing at the eight-day Tour du Rwanda on Sunday. Stage 8 is an 82.2-km circuit race around Kigali. The final stage includes seven categorized climb, including the Kigali Wall, and two intermediate sprints.

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes UCI Professional Continental cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

All images are ©NILS LAENGNER

SOURCE Team Novo Nordisk


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: